Monophasic –
Polydensified –

REVOLAX has a monophasic structure of regular and dense lattice which allows consistent smooth injection throughout the treatment and helps to naturally harmonise volume, look and feel.

REVOLAX’s dense and regular patterns, unlike most other HA Monophasic fillers, make the structure more solid and durable whilst maintaining viscosity and elasticity.

The product has been designed to appear natural-looking over the full course of time up until the point that it is fully absorbed into the skin.


REVOLAX dermal fillers are highly structured, monophasic, and densely linked HA polymer that are enabled to last up to 18 months – product dependent.

material properties
Revolax™ Fine
With Lidocaine
Revolax™ Deep
With Lidocaine
Revolax™ SubQ
With Lidocaine
Composition HA 24mg/ml Lidocaine 0.3% HA 24mg/ml Lidocaine 0.3% HA 24mg/ml Lidocaine 0.3%
Recommended Indications Superficial lines;
Worry Lines
Crow’s Feet
Neck Wrinkles
Deep Nasolabial Folds
Face Contouring and Augmentation.
Severely Deep Lines
Cheeks / Chin Contouring and Augmentation.
Injection Depth Superficial Dermis Mid/Deep Dermis, Subcutaneous Deep Subcutaneous
Volume 1.1ml 1.1ml 1.1ml
Complex Viscosity 80 160 280
Needle Size 30G 27G 25G
Duration 8 – 12 Months 12 – 18 Months 12 – 18 Months
Storage 2 – 25°C 2 – 25°C 2 – 25°C
Shelf life 24 Months 24 Months 24 Months
Hyaluronic Acid: derived from streptococcus zooepidemicus
Crosslinked HA : 100%
Crosslinking Agent: BDDE
BDDE Residue in final product: Not Detected

REVOLAX with Lidocaine must
not be used in:

  • Women who are pregnant or breastfeeding.
  • People under age of 18.
  • Patients who are known to demonstrate hypersensitivity to hyaluronic acid.
  • Patients who are known to demonstrate hypersensitivity to lidocaine.
  • Patients who tend to develop hypertrophic scarring.
  • Immediately before or post laser therapy, chemical peeling or derma-brasion.
  • Areas presenting cutaneous inflammation or signs of infection.